Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
The FEBS Journal|August 18, 2009
The miRNA-192/194 cluster regulates the Period gene family and the circadian clockRemco Nagel, Linda Clijsters, Reuven AgamiEMBO Reports|October 6, 2016
Drugging the addict: non-oncogene addiction as a target for cancer therapyRemco Nagel, Ekaterina A Semenova, Anton BernsGenes & Development|July 30, 2015
Origins, genetic landscape, and emerging therapies of small cell lung cancerEkaterina A Semenova, Remco Nagel, Anton BernsCell Cycle (Georgetown, Tex.)|November 8, 2007
Diverse ways to control p27Kip1 function: miRNAs come into playCarlos le Sage, Remco Nagel, Reuven AgamiCancer Research|July 29, 2022
Boosting Antitumor Immunity with an Expanded Neoepitope LandscapeRemco Nagel, Abhijeet Pataskar, Julien Champagne, et al.Trends in Genetics : TIG|May 31, 2022
Slippy-Sloppy translation: a tale of programmed and induced-ribosomal frameshiftingJulien Champagne, Kelly Mordente, Remco Nagel, et al.Oral Oncology|April 13, 2013
Treatment response of HPV-positive and HPV-negative head and neck squamous cell carcinoma cell linesRemco Nagel, Sanne R Martens-de Kemp, Marijke Buijze, et al.Cancer Research|July 18, 2008
Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancerRemco Nagel, Carlos le Sage, Begoña Diosdado, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
Functional genetic screens identify genes essential for tumor cell survival in head and neck and lung cancerSanne R Martens-de Kemp, Remco Nagel, Marijke Stigter-van Walsum, et al.Journal of Proteomics|February 3, 2019
Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response predictionFranziska Böttger, Tieneke B Schaaij-Visser, Inge de Reus, et al.Pageof 3